Benzinga | May 11, 2021 04:33PM EDT

Exagen Q1 EPS $(0.48) Misses $(0.47) Estimate, Sales $10.59M Beat $10.45M Estimate

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.47) by 2.13 percent. This is a 9.09 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $10.59 million which beat the analyst consensus estimate of $10.45 million by 1.31 percent. This is a 10.47 percent increase over sales of $9.58 million the same period last year.